Professor M Francesca Cordeiro Professor of ophthalmology and honorary consultant opthalmologist

Background

Professor M Francesca Cordeiro is a clinician-scientist, chair of ophthalmology at Imperial College London, University College London (UCL) professor of glaucoma and retinal neurodegeneration, honorary consultant ophthalmologist and research lead and director of the clinical trials unit at the Western Eye Hospital, London. She qualified in medicine from St Bartholomew's Hospital University of London and completed training in general and surgical ophthalmology at Moorfields Eye and St Thomas’ hospitals in London in 2003, following her PhD at UCL in 1998. Her research, mainly funded through the Wellcome Trust, is focused on the molecular mechanisms involved in either the treatment or pathogenesis of retinal neurodegenerative diseases, including glaucoma, Alzheimer’s, Parkinson’s and diabetes. She has investigated novel and translational approaches to these problems, with a target of saving sight and reducing disability. She has received a number of international awards for this work, including the Lewis Rudin Glaucoma Prize 2005 from the New York Academy of Medicine, the Research to Prevent Blindness International Research Scholar Award USA 2015 and the GG2 Diversity Award for Outstanding Achievement in Medicine 2017. She serves on various international committees including the Association for Research in Vision and Ophthalmology (ARVO), European Vision Institute, Controversies in Ophthalmology (COphy), European Glaucoma Society (EGS), EVICRnet and European Association for Vision and Eye Research (EVER), and chairs the EGS Neuroprotection SIG. She is editorial board member/associate of various journals including Investigative Ophthalmology & Visual Science (IOVS), Experimental Eye Research and Ophthalmic Research. Having previously been a graduate tutor at UCL, she teaches and mentors undergraduates and postgraduates at Imperial College and UCL, and is a trustee for the Fight for Sight charity.

Expertise

Retinal neurodegeneration, glaucoma

Research & publications

Cordeiro MF, Normando EM, Cardoso MJ, Miodragovic S, Jeylani S, Davis BM, Guo L, Ourselin S, A'Hern R, Bloom PA. (2017)  Real-time imaging of single neuronal cell apoptosis in patients with glaucoma. Brain. Jun 2017 1;140(6):1757-67. 

Davis BM, Normando EM, Guo L, Tilley MW, OShea P. Moss SE, Somavarapu A, Cordeiro MF (2014) Topical delivery of avastin to the posterior segment of the eye using annexin A5-associated lipid nanoparticles. SMALL, 2014 Apr;10(8):1575-84 

Guo L, Salt TE, Luong V, Wood NE, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, Moss SE, Fitzke FW, Cordeiro MF (2007) Targeting Amyloid-ß in glaucoma treatment. Proceedings of the National Academy of Science 2007; 104(33):13444-13449

Cordeiro, MF, Guo L, Luong V, Harding G, Wang W, Jones HE, Moss SE, Sillito AM & Fitzke FW (2004) Real time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proceedings of the National Academy of Science 2004; 101: 13352-13356.

Cordeiro MF, Gay JA and Khaw PT (1999) Human Anti-TGF-ß2 monoclonal antibody: a new antiscarring agent for glaucoma filtration surgery. Investigative Ophthalmology and Visual Science, 1999; 40: 2225-34.